ATE160779T1 - Antipsychotische indazolderivate - Google Patents

Antipsychotische indazolderivate

Info

Publication number
ATE160779T1
ATE160779T1 AT94909210T AT94909210T ATE160779T1 AT E160779 T1 ATE160779 T1 AT E160779T1 AT 94909210 T AT94909210 T AT 94909210T AT 94909210 T AT94909210 T AT 94909210T AT E160779 T1 ATE160779 T1 AT E160779T1
Authority
AT
Austria
Prior art keywords
pct
indazole derivatives
sec
dopamine
antipsychotic
Prior art date
Application number
AT94909210T
Other languages
English (en)
Inventor
Raymond Baker
Janusz Jozef Kulagowski
Paul David Leeson
Adrian Leonard Smith
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE160779T1 publication Critical patent/ATE160779T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT94909210T 1993-03-18 1994-03-14 Antipsychotische indazolderivate ATE160779T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305623A GB9305623D0 (en) 1993-03-18 1993-03-18 Therapeutic agents

Publications (1)

Publication Number Publication Date
ATE160779T1 true ATE160779T1 (de) 1997-12-15

Family

ID=10732311

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94909210T ATE160779T1 (de) 1993-03-18 1994-03-14 Antipsychotische indazolderivate

Country Status (10)

Country Link
US (1) US5780475A (de)
EP (1) EP0689539B1 (de)
JP (1) JPH08512284A (de)
AT (1) ATE160779T1 (de)
AU (1) AU685090B2 (de)
CA (1) CA2156838A1 (de)
DE (1) DE69407174T2 (de)
ES (1) ES2110225T3 (de)
GB (1) GB9305623D0 (de)
WO (1) WO1994021630A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9324244D0 (en) * 1993-11-25 1994-01-12 Merck Sharp & Dohme Therapeutic agents
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する1−アリールアルキル−4−(アルコキシピリジニル)−又は4−(アルコキシピリミジニル)ピペラジン誘導体
AU7319096A (en) * 1995-11-02 1997-05-22 Merck Sharp & Dohme Limited Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation and their use as selective agonists of 5-ht1-like receptors
GB9524356D0 (en) * 1995-11-29 1996-01-31 Merck Sharp & Dohme Therapeutic agents
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
DE19637237A1 (de) 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate
WO1998035942A1 (en) * 1997-02-18 1998-08-20 American Home Products Corporation 4-aminoethoxyindazole derivatives
US5872144A (en) * 1997-02-18 1999-02-16 American Home Products Corporation 4-aminoethoxyindazole derivatives
IL126745A (en) * 1997-11-04 2003-09-17 Pfizer Prod Inc Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors
WO2000012500A2 (en) * 1998-09-02 2000-03-09 Neurogen Corporation 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands
US6355801B1 (en) 1999-11-08 2002-03-12 Schering Corporation Process for preparing N-(4-hydroxyphenyl)-N′-(4′-aminophenyl)-piperazine
HUP0203645A3 (en) * 1999-12-30 2004-01-28 Lundbeck & Co As H Phenylpiperazinyl derivatives, pharmaceutical compositions containing them and their use
AR035521A1 (es) * 2000-12-22 2004-06-02 Lundbeck & Co As H Derivados de 3-indolina y composicion farmaceutica que los comprende
US20050256130A1 (en) * 2002-06-12 2005-11-17 Chemocentryx, Inc. Substituted piperazines
KR101255356B1 (ko) 2002-06-12 2013-04-17 케모센트릭스, 인크. 염증 및 면역 질병의 치료를 위한 ccr1 길항물질로서사용하기 위한 1-아릴-4-치환된 피페라진 유도체
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
US7842693B2 (en) * 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
US7435831B2 (en) * 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
JP4845873B2 (ja) * 2004-03-03 2011-12-28 ケモセントリックス インコーポレーティッド 二環式および架橋した窒素複素環
AR050253A1 (es) 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
ATE460415T1 (de) * 2004-11-29 2010-03-15 Warner Lambert Co Therapeutische pyrazoloä3,4-büpyridine und - indazole
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
US8354539B2 (en) 2009-03-10 2013-01-15 Glaxo Group Limited Indole derivatives as IKK2 inhibitors
US9238643B2 (en) 2010-09-06 2016-01-19 Guangzhou Institutes Of Biomedicine And Health, Chinese Academy Of Sciences Amide compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
US3678059A (en) * 1969-10-07 1972-07-18 Ciba Geigy Corp 3-aminoalkylidene-indazoles
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
GB8900382D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
DE69232907T2 (de) * 1991-03-28 2003-05-15 Eisai Co Ltd Neue heterocyclische/cyclische amine
PL310443A1 (en) * 1993-03-01 1995-12-11 Merck Sharp & Dohme Derivatives of pyrolo-pyridine
GB9305641D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
DE69407174T2 (de) 1998-07-02
CA2156838A1 (en) 1994-09-29
EP0689539A1 (de) 1996-01-03
EP0689539B1 (de) 1997-12-03
DE69407174D1 (de) 1998-01-15
WO1994021630A1 (en) 1994-09-29
US5780475A (en) 1998-07-14
GB9305623D0 (en) 1993-05-05
JPH08512284A (ja) 1996-12-24
AU685090B2 (en) 1998-01-15
ES2110225T3 (es) 1998-02-01
AU6214094A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
ATE160779T1 (de) Antipsychotische indazolderivate
GB9306578D0 (en) Therapeutic agents
NO953406L (no) Pyrrolo-pyridinderivater
ES2121193T3 (es) Derivados de bencimidazoles.
AR016453A1 (es) Pirazolopirimidinas y perazolotriazinas, un procedimiento para su preparacion, medicamentos y el uso de las mismas para la elaboracion de los medicamentos
ES2134929T3 (es) Derivados de pirrolo-piridina como ligandos para receptores de dopamina.
HK1049284A1 (en) Benzimidazole compounds having nociceptin receptoraffinity
NO952687D0 (no) Tiazolidinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene
EE03487B1 (et) 5-fenüül-3-(piperidin-4-üül)-1,3,4-oksadiasol-2(3H)-ooni derivaadid kasutamiseks 5-HT4 - või H3- retseptorite ligandidena
MXPA04005847A (es) Compuestos derivados de 4-sulfuro/sulfoxido/sulfonil-1h-pirazolilo, para uso en enfermedades asociadas con el receptor 5-ht2c.
GEP20032868B (en) Triazolo-Pyridazine Derivatives as Ligands for Gaba Receptors, Methods for Their Production, Pharmaceutical Compositions Containing the Same for Treatment and/or Prevention of disorders of Central Nervous System
KR900000092A (ko) 신경 장애의 치료에 있어서 유리딘의 약리학적 용도
DE69930308D1 (de) Selektive 5-ht 6-rezeptor-liganden
BG106509A (en) Preparative form
SE8801275D0 (sv) New uses of dopamine agonists
ES2176199T3 (es) Derivados de indol como agonistas de s-ht1.
GB9305641D0 (en) Therapeutic agents
ES2126773T3 (es) Derivados triciclicos heteroaromaticos condensados como ligandos de subtipos de receptores de dopamina.
GB9318691D0 (en) Therapeutic agents
DE69412073D1 (de) Xanthinderivate als adenosin-a1 rezeptor antagonisten
AU5614198A (en) Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
PE108498A1 (es) Ligandos espirociclicos de un subtipo de receptor de la dopamina
TR199701756T1 (xx) 5-HT e�ilimli resept�re sahip yo�unla�t�r�lm�� tiazol t�revleri.